Loading...
Maxim Pharmaceuticals Private Limited — Cefpodoxime Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Cefpodoxime · $404.9K export value · DGFT Verified
Maxim Pharmaceuticals Private Limited is the #11 Indian exporter of Cefpodoxime with $404.9K in export value and 17 verified shipments. Maxim Pharmaceuticals Private Limited holds a 0.5% market share in Cefpodoxime exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $12.2M | 244 | 37.1% |
| FRANCE | $4.6M | 160 | 14.0% |
| SUDAN | $3.1M | 139 | 9.3% |
| VIETNAM | $2.6M | 107 | 7.8% |
| MACEDONIA,THE FORMER YUGOSLAV REPUBLIC OF | $2.2M | 97 | 6.7% |
| SOUTH AFRICA | $1.5M | 36 | 4.5% |
| GERMANY | $1.4M | 32 | 4.3% |
| GREECE | $1.1M | 23 | 3.5% |
| BELGIUM | $993.3K | 30 | 3.0% |
| NORTH MACEDONIA | $782.3K | 28 | 2.4% |
India exports Cefpodoxime to 78 countries. The top destination is UNITED STATES (37.1%), followed by FRANCE and SUDAN.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALKALOID AD SKOPJE | NORTH MACEDONIA | $2.6M | 68 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $2.0M | 60 |
| CRONUS PHARMA LLC | UNITED STATES | $1.3M | 26 |
| CRONUS PHARMA LLC, | UNITED STATES | $1.1M | 21 |
| AUROBINDO PHARMA USA.,INC | UNITED STATES |
India exported $33.7M worth of Cefpodoxime through 1,734 shipments from 178 suppliers to 78 countries, serving 442 buyers globally. Maxim Pharmaceuticals Private Limited contributes $404.9K to this total, accounting for 0.5% of India's Cefpodoxime exports.
Maxim Pharmaceuticals Private Limited's average Cefpodoxime shipment value is $23.8K per consignment, based on 17 shipments totaling $404.9K.
Maxim Pharmaceuticals Private Limited ranks #11 among 178 Indian Cefpodoxime exporters with a 0.5% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), LUPIN LIMITED ($10.6M), AUROBINDO PHARMA LIMITED ($4.5M). Maxim Pharmaceuticals Private Limited processed 17 shipments to 1 destination countries.
What Maxim Pharmaceuticals Private Limited must comply with to export Cefpodoxime to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MEDINOK HEALTHCARE PRIVATE LIMITED | $500.0K | 10 | 1 | $50.0K |
| 10 | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI | $497.8K | 35 | 2 | $14.2K |
| 11 | MAXIM PHARMACEUTICALS PRIVATE LIMITED ★ | $404.9K | 17 | 1 | $23.8K |
| 12 | AJANTA PHARMA LIMITED | $330.9K |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 174 | 10.0% |
| SAHAR AIR | 166 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 133 | 7.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 128 | 7.4% |
| JNPT | 88 | 5.1% |
| DELHI AIR | 81 | 4.7% |
| HYDERABAD ICD | 79 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 78 | 4.5% |
Latest developments and market context
Detailed market intelligence for Cefpodoxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maxim Pharmaceuticals Private Limited's Cefpodoxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| $800.0K |
| 16 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $700.0K | 14 |
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $550.0K | 11 |
| MCKESSON THIRD PARTY LOGISTICS | UNITED STATES | $400.0K | 8 |
| AMICI PHARMACEUTICALS | UNITED STATES | $300.0K | 6 |
| AUROLOGISTICS LLC | UNITED STATES | $250.0K | 5 |
India's Cefpodoxime is purchased by 442 buyers worldwide. The top buyer is ALKALOID AD SKOPJE (NORTH MACEDONIA), followed by NORTHSTAR DISTRIBUTION CENTER 8912 and CRONUS PHARMA LLC.
| 46 |
| 4 |
| $7.2K |
| 13 | MACLEODS PHARMACEUTICALS LTD | $321.9K | 12 | 3 | $26.8K |
Maxim Pharmaceuticals Private Limited ranks #11 among 178 Indian Cefpodoxime exporters. Average shipment value of $23.8K compared to the market average of $189.3K. The closest competitors by value are MEDINOK HEALTHCARE PRIVATE LIMITED and SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 78+ countries, 442+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Maxim Pharmaceuticals Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefpodoxime. For current shipment-level data, contact TransData Nexus.